UB Paderborn / Katalog / Suche / in CDI

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2016-12, Vol.12 (11), p.e1404

2016

Link zum Volltext

Verfügbarkeit prüfen

Real-world evidence of switching P2Y12 receptor-inhibiting therapies to prasugrel after PCI in patients with ACS: results from EFF-K registry

BMC cardiovascular disorders, 2023-01, Vol.23 (1), p.6-6, Article 6

2023

Link zum Volltext

Verfügbarkeit prüfen

2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Journal of the American College of Cardiology, 2014-12, Vol.64 (24), p.e139-e228

2014

Link zum Volltext

Verfügbarkeit prüfen

Impact of Close Surveillance on Dual-Antiplatelet Therapy Compliance in Myocardial Infarction Patients Post-Percutaneous Coronary Intervention

Cardiovascular revascularization medicine, 2023-03, Vol.48, p.7-14

2023

Link zum Volltext

Verfügbarkeit prüfen

Timing, Selection, Modulation, and Duration of P2Y 12 Inhibitors for Patients With Acute Coronary Syndromes Undergoing PCI

JACC. Cardiovascular interventions, 2023-01, Vol.16 (1), p.1

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 8.955

Suche als RSS-Feed

Aktive Filter

KollektionJournals@Ovid Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(7.885)
Mit Volltextzugriff
(7.152)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(7.456)
Science & Technology
(6.560)
Life Sciences & Biomedicine
(6.336)
Male
(3.992)
Cardiovascular System & Cardiology
(3.940)
Female
(3.828)
Cardiac & Cardiovascular Systems
(3.713)
Acute Coronary Syndromes
(3.489)
Middle Aged
(3.227)
Aged
(3.020)
Acute Coronary Syndrome
(2.682)
Acute Coronary Syndrome - Therapy
(2.443)
Treatment Outcome
(2.338)
Acute Coronary Syndrome - Drug Therapy
(1.965)
Risk Factors
(1.873)
Heart Attacks
(1.793)
Cardiology
(1.664)
Cardiovascular Disease
(1.511)
Mortality
(1.259)
Platelet Aggregation Inhibitors - Therapeutic Use
(1.239)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Timing of Coronary Invasive Strategy in Non-ST-Segment Elevation Acute Coronary Syndromes and Clinical Outcomes: An Updated Meta-Analysis

2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the Use of Antiplatelet Therapy

Sex differences in time trends in acute coronary syndrome management and in 12-month lethality: Data from the French MONICA registries

A Risk Score to Predict Bleeding in Patients With Acute Coronary Syndromes

Management of Acute Coronary Syndromes

Early and Late Benefits of Prasugrel in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention : A TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) Analysis

Efficacy of high-dose atorvastatin or rosuvastatin loading in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials with GRADE qualification of available evidence

Optimizing P2Y12 Receptor Inhibition in Patients With Acute Coronary Syndrome on the Basis of Platelet Function Testing: Impact of Prasugrel and High-Dose Clopidogrel

Contemporary Management of Stable Coronary Artery Disease　― Implications of the ISCHEMIA Trial

Clinical Impact of CYP2C19 Genotype on Clopidogrel-Based Antiplatelet Therapy After Percutaneous Coronary Intervention

Randomized evaluation of 5-month Ticagrelor monotherapy after 1-month dual-antiplatelet therapy in patients with acute coronary syndrome treated with drug-coated balloons: REC-CAGEFREE II trial rationale and design

Rationale and design of the optimal antithrombotic treatment for acute coronary syndrome patients with concomitant atrial fibrillation and implanted with new‐generation drug‐eluting stent: OPtimal management of anTIthroMbotic Agents (OPTIMA)‐4 trial

The Effects of the COVID-19 Pandemic on the Clinical Practices of Cardiologists

Management of acute coronary syndrome : ESC guidelines 2023

Acute coronary syndrome in patients treated by vitamin K antagonists or non-vitamin K antagonist oral anticoagulants: Proposed management algorithm for the first 48hours

Efficacy and Safety of Ticagrelor versus Clopidogrel with Different Dosage in High-risk Patients with Acute Coronary Syndrome

Short Duration of DAPT vs De-Escalation After Percutaneous Coronary Intervention for Acute Coronary Syndromes

Reply: Short Duration of DAPT vs De-Escalation After Percutaneous Coronary Intervention for Acute Coronary Syndromes

Evaluation of pharmacist-led transition of care program in patients with acute coronary syndrome

Regular drug-eluting stents versus the dedicated coronary bifurcation sirolimus-eluting BiOSS LIM® stent: the randomised, multicentre, open-label, controlled POLBOS II trial

Real-world evidence of switching P2Y12 receptor-inhibiting therapies to prasugrel after PCI in patients with ACS: results from EFF-K registry

2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Impact of Close Surveillance on Dual-Antiplatelet Therapy Compliance in Myocardial Infarction Patients Post-Percutaneous Coronary Intervention

Timing, Selection, Modulation, and Duration of P2Y 12 Inhibitors for Patients With Acute Coronary Syndromes Undergoing PCI

Aktive Filter

Suchergebnisse filtern